Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Beyond the Endpoint and Duke Clinical Research Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beyond the Endpoint and Duke Clinical Research Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Obesity, GLP-1s, and the Evidence: What the Data Tells Us

31:04
 
Share
 

Manage episode 515133242 series 1417049
Content provided by Beyond the Endpoint and Duke Clinical Research Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beyond the Endpoint and Duke Clinical Research Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this second episode of our obesity series, preventive cardiologist Neha Pagidipati sheds light on the discovery, impact, and uses of GLP-1s, like Ozempic and Mounjaro. Learn about the impact these medications are having on diabetes, heart disease, and weight management. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-4-obesity-glp-1s-and-evidence-what-data-tells-us
  continue reading

36 episodes

Artwork
iconShare
 
Manage episode 515133242 series 1417049
Content provided by Beyond the Endpoint and Duke Clinical Research Institute. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Beyond the Endpoint and Duke Clinical Research Institute or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
In this second episode of our obesity series, preventive cardiologist Neha Pagidipati sheds light on the discovery, impact, and uses of GLP-1s, like Ozempic and Mounjaro. Learn about the impact these medications are having on diabetes, heart disease, and weight management. 🔗 Access resources related to this episode: https://dcri.org/blog/s2-ep-4-obesity-glp-1s-and-evidence-what-data-tells-us
  continue reading

36 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play